Ingram INGM Stock Consolidating at 2566 Next Move Ahead 20260520 Costco COST Q1 2026 Results Miss Estimates EPS 458 vs 465 DraftKings DKNG Reports Strong Q1 2026 Revenue NA EPS Beats Eltek ELTK Q1 2026 Earnings No Surprises But Whats Next SpaceX IPO Charts Reveal Spending Patterns Mimicking AI Giants Ahead of Potential Public Listing Weak Market Breadth Sidelines Nifty as Consolidation Persists Consumer Price Index Rises 38 in April Marking Highest Annual Gain Since May 2023 Oil Prices Decline for the Week as USIran Talks Show Progress Key Differences Remain US Q1 GDP Growth Revised Down to 16 Annual Rate Government Reports Evercore ISI Raises Price Target on Cummins Inc CMI GOVX Q1 2026 Earnings Narrower Loss Surprises Shares Surge Over 32 SCL Q1 2026 Earnings Slight EPS Beat Drives Positive Market Response CNTY Q1 2026 Earnings EPS Surpasses Estimate Despite Net Loss Brighthouse Financial Preferred Stock BHFAP Q1 2026 Earnings Preferred Stock EPS Misses Estimates Amid Market Challenges MLEC Q2 2025 Earnings EPS Surprises to the Upside as PreRevenue Science Company Narrows Loss SQM Q2 2025 Earnings EPS of 031 Reported Amid Lithium Market Headwinds Shares Rise 112 Tempus AI TEM Slightly Lower as Shares Consolidate Near Support Levels Rafael Holdings RFL Shows Modest Uptick as Shares Test Key Resistance Levels Magic Empire Global MEGL Slips Slightly but Holds Key Support Zone XChange TECINC XHG Holds Steady at 098 Consolidation or Stalemate Cybin Inc HELP Rises 158 as Psychedelic Stock Tests Resistance at 473 OFSSH Holds Steady at 239 as FixedIncome Market Takes a Breather Gores Holdings X Inc Warrants GTENW Hold Steady at 065 Key Levels in Focus Popular Inc BPOP Edges Higher on Modest Gains Testing Key Resistance Zone Otis Worldwide OTIS Holds Near 72 as Minor Decline Tests Support Zone iQSTEL Inc IQST Faces Resistance After Pullback from Key Level Post Office Horizon Scandal Inquiry Faces FiveYear Delay Without Extra Funding Police Warn AREC Q3 2025 Earnings SmallerThanExpected Loss Signals Operational Progress Trevi Therapeutics TRVI Holds Near Resistance After Modest Gain